Derivatives of EPA endocannabinoid epoxides as anti-inflammatory, anti-cancerous, anti-angiogenc and antiplatelet aggregation compounds

Aditi Das (Inventor), Josephine E Watson (Inventor)

Research output: Patent

Abstract

The present disclosure provides chemical compound derivatives of a class of biological lipid mediators known as endocannabinoids and methods of synthesizing the compositions. These compounds are useful for treating cancer, reducing inflammation, reducing platelet aggregation, and reducing angiogenesis.
Original languageEnglish (US)
U.S. patent number11407728
Filing date9/20/18
StatePublished - Aug 9 2022

Fingerprint

Dive into the research topics of 'Derivatives of EPA endocannabinoid epoxides as anti-inflammatory, anti-cancerous, anti-angiogenc and antiplatelet aggregation compounds'. Together they form a unique fingerprint.

Cite this